Palisade Bio (PALI) Operating Margin Growth (3y) (2014 - 2023)
Palisade Bio (PALI) Operating Margin Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 828,504.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7,261.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -50,506.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -2,649.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 9,003.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 30,461.00 |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.21 Mn |
| Dec 31, 2020 | -12.89 Mn |
| Sep 30, 2020 | 3.09 Mn |
| Jun 30, 2020 | 9.51 Mn |
| Mar 31, 2020 | 13.62 Mn |
| Dec 31, 2019 | -2.07 Mn |
| Sep 30, 2019 | 11.17 Mn |
| Jun 30, 2019 | 12.91 Mn |
| Mar 31, 2019 | 15.11 Mn |
| Dec 31, 2018 | 10.19 Mn |
| Sep 30, 2018 | 12.46 Mn |
| Jun 30, 2018 | 19.90 Mn |
| Mar 31, 2018 | 6.42 Mn |
| Dec 31, 2017 | 9.86 Mn |
| Sep 30, 2017 | -2.14 Mn |
| Jun 30, 2017 | -9.85 Mn |
| Mar 31, 2017 | -4.50 Mn |
| Dec 31, 2016 | 4.59 Mn |
| Sep 30, 2016 | -5.13 Mn |
| Jun 30, 2016 | -2.39 Mn |